Socioeconomic and insurance-related disparities in disease-specific survival among patients with metastatic bone disease.
Muhammad Umar JawadBrad H PollockBarton L WiseLauren N ZeitlingerEdmond F O' DonnellJanai R Carr-AscherAmy M CizikBetty FerrellSteven W ThorpeRobert Lor RandallPublished in: Journal of surgical oncology (2022)
MBD patients from the five most common primary sites demonstrated SES and insurance-related disparities in disease-specific survival. This is the first and largest study to explore SES and insurance-related disparities among patients specifically afflicted with MBD. Our findings highlight vulnerability of patients with MBD across multiple primary sites to financial toxicity.